Pre-order Enquiry
Request Free Sample
Global Peripheral Intervention Drug-Eluting Devices Market Research Report 2021
SKU ID : QYR-17289270 | Publishing Date : 28-Jan-2021 | No. of pages : 90
Request Sample
Request Customization
Check DiscountsDetailed TOC of Global Peripheral Intervention Drug-Eluting Devices Market Research Report 2021
1 Peripheral Intervention Drug-Eluting Devices Market Overview1.1 Product Overview and Scope of Peripheral Intervention Drug-Eluting Devices
1.2 Peripheral Intervention Drug-Eluting Devices Segment by Type
1.2.1 Global Peripheral Intervention Drug-Eluting Devices Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Plain Old Balloon Angioplasty (POBA)
1.2.3 Percutaneous Transluminal Angioplasty (PTA)
1.3 Peripheral Intervention Drug-Eluting Devices Segment by Application
1.3.1 Peripheral Intervention Drug-Eluting Devices Sales Comparison by Application: (2021-2027)
1.3.2 Drug-Eluting Balloons
1.3.3 Drug-Eluting Stents
1.4 Global Peripheral Intervention Drug-Eluting Devices Market Size Estimates and Forecasts
1.4.1 Global Peripheral Intervention Drug-Eluting Devices Revenue 2016-2027
1.4.2 Global Peripheral Intervention Drug-Eluting Devices Sales 2016-2027
1.4.3 Peripheral Intervention Drug-Eluting Devices Market Size by Region: 2016 Versus 2021 Versus 2027
2 Peripheral Intervention Drug-Eluting Devices Market Competition by Manufacturers
2.1 Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Manufacturers (2016-2021)
2.2 Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Peripheral Intervention Drug-Eluting Devices Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Peripheral Intervention Drug-Eluting Devices Manufacturing Sites, Area Served, Product Type
2.5 Peripheral Intervention Drug-Eluting Devices Market Competitive Situation and Trends
2.5.1 Peripheral Intervention Drug-Eluting Devices Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Peripheral Intervention Drug-Eluting Devices Players Market Share by Revenue
2.5.3 Global Peripheral Intervention Drug-Eluting Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Peripheral Intervention Drug-Eluting Devices Retrospective Market Scenario by Region
3.1 Global Peripheral Intervention Drug-Eluting Devices Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Peripheral Intervention Drug-Eluting Devices Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Peripheral Intervention Drug-Eluting Devices Market Facts & Figures by Country
3.3.1 North America Peripheral Intervention Drug-Eluting Devices Sales by Country
3.3.2 North America Peripheral Intervention Drug-Eluting Devices Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Peripheral Intervention Drug-Eluting Devices Market Facts & Figures by Country
3.4.1 Europe Peripheral Intervention Drug-Eluting Devices Sales by Country
3.4.2 Europe Peripheral Intervention Drug-Eluting Devices Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Peripheral Intervention Drug-Eluting Devices Market Facts & Figures by Region
3.5.1 Asia Pacific Peripheral Intervention Drug-Eluting Devices Sales by Region
3.5.2 Asia Pacific Peripheral Intervention Drug-Eluting Devices Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Peripheral Intervention Drug-Eluting Devices Market Facts & Figures by Country
3.6.1 Latin America Peripheral Intervention Drug-Eluting Devices Sales by Country
3.6.2 Latin America Peripheral Intervention Drug-Eluting Devices Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Peripheral Intervention Drug-Eluting Devices Market Facts & Figures by Country
3.7.1 Middle East and Africa Peripheral Intervention Drug-Eluting Devices Sales by Country
3.7.2 Middle East and Africa Peripheral Intervention Drug-Eluting Devices Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Peripheral Intervention Drug-Eluting Devices Historic Market Analysis by Type
4.1 Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Type (2016-2021)
4.2 Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Type (2016-2021)
4.3 Global Peripheral Intervention Drug-Eluting Devices Price by Type (2016-2021)
5 Global Peripheral Intervention Drug-Eluting Devices Historic Market Analysis by Application
5.1 Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Application (2016-2021)
5.2 Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Application (2016-2021)
5.3 Global Peripheral Intervention Drug-Eluting Devices Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Medtronic plc
6.1.1 Medtronic plc Corporation Information
6.1.2 Medtronic plc Description and Business Overview
6.1.3 Medtronic plc Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Medtronic plc Product Portfolio
6.1.5 Medtronic plc Recent Developments/Updates
6.2 Boston Scientific Corporation
6.2.1 Boston Scientific Corporation Corporation Information
6.2.2 Boston Scientific Corporation Description and Business Overview
6.2.3 Boston Scientific Corporation Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Boston Scientific Corporation Product Portfolio
6.2.5 Boston Scientific Corporation Recent Developments/Updates
6.3 Abbott Laboratories
6.3.1 Abbott Laboratories Corporation Information
6.3.2 Abbott Laboratories Description and Business Overview
6.3.3 Abbott Laboratories Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Abbott Laboratories Product Portfolio
6.3.5 Abbott Laboratories Recent Developments/Updates
6.4 Cardinal Health
6.4.1 Cardinal Health Corporation Information
6.4.2 Cardinal Health Description and Business Overview
6.4.3 Cardinal Health Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Cardinal Health Product Portfolio
6.4.5 Cardinal Health Recent Developments/Updates
6.5 B. Braun Melsungen AG
6.5.1 B. Braun Melsungen AG Corporation Information
6.5.2 B. Braun Melsungen AG Description and Business Overview
6.5.3 B. Braun Melsungen AG Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Gross Margin (2016-2021)
6.5.4 B. Braun Melsungen AG Product Portfolio
6.5.5 B. Braun Melsungen AG Recent Developments/Updates
6.6 Biosensors International Group Ltd.
6.6.1 Biosensors International Group Ltd. Corporation Information
6.6.2 Biosensors International Group Ltd. Description and Business Overview
6.6.3 Biosensors International Group Ltd. Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Biosensors International Group Ltd. Product Portfolio
6.6.5 Biosensors International Group Ltd. Recent Developments/Updates
6.7 C.R. Bard, Inc.
6.6.1 C.R. Bard, Inc. Corporation Information
6.6.2 C.R. Bard, Inc. Description and Business Overview
6.6.3 C.R. Bard, Inc. Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Gross Margin (2016-2021)
6.4.4 C.R. Bard, Inc. Product Portfolio
6.7.5 C.R. Bard, Inc. Recent Developments/Updates
6.8 Abbott
6.8.1 Abbott Corporation Information
6.8.2 Abbott Description and Business Overview
6.8.3 Abbott Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Abbott Product Portfolio
6.8.5 Abbott Recent Developments/Updates
6.9 The Lubrizol Corporation
6.9.1 The Lubrizol Corporation Corporation Information
6.9.2 The Lubrizol Corporation Description and Business Overview
6.9.3 The Lubrizol Corporation Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Gross Margin (2016-2021)
6.9.4 The Lubrizol Corporation Product Portfolio
6.9.5 The Lubrizol Corporation Recent Developments/Updates
6.10 Terumo Corporation
6.10.1 Terumo Corporation Corporation Information
6.10.2 Terumo Corporation Description and Business Overview
6.10.3 Terumo Corporation Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Terumo Corporation Product Portfolio
6.10.5 Terumo Corporation Recent Developments/Updates
7 Peripheral Intervention Drug-Eluting Devices Manufacturing Cost Analysis
7.1 Peripheral Intervention Drug-Eluting Devices Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Peripheral Intervention Drug-Eluting Devices
7.4 Peripheral Intervention Drug-Eluting Devices Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Peripheral Intervention Drug-Eluting Devices Distributors List
8.3 Peripheral Intervention Drug-Eluting Devices Customers
9 Peripheral Intervention Drug-Eluting Devices Market Dynamics
9.1 Peripheral Intervention Drug-Eluting Devices Industry Trends
9.2 Peripheral Intervention Drug-Eluting Devices Growth Drivers
9.3 Peripheral Intervention Drug-Eluting Devices Market Challenges
9.4 Peripheral Intervention Drug-Eluting Devices Market Restraints
10 Global Market Forecast
10.1 Peripheral Intervention Drug-Eluting Devices Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Peripheral Intervention Drug-Eluting Devices by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Peripheral Intervention Drug-Eluting Devices by Type (2022-2027)
10.2 Peripheral Intervention Drug-Eluting Devices Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Peripheral Intervention Drug-Eluting Devices by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Peripheral Intervention Drug-Eluting Devices by Application (2022-2027)
10.3 Peripheral Intervention Drug-Eluting Devices Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Peripheral Intervention Drug-Eluting Devices by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Peripheral Intervention Drug-Eluting Devices by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Figures, Tables and Charts Available in Global Peripheral Intervention Drug-Eluting Devices Market Research Report 2021
List of TablesTable 1. Global Peripheral Intervention Drug-Eluting Devices Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Peripheral Intervention Drug-Eluting Devices Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Peripheral Intervention Drug-Eluting Devices Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Peripheral Intervention Drug-Eluting Devices Covered in This Study
Table 5. Global Peripheral Intervention Drug-Eluting Devices Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Peripheral Intervention Drug-Eluting Devices Sales Share by Manufacturers (2016-2021)
Table 7. Global Peripheral Intervention Drug-Eluting Devices Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Peripheral Intervention Drug-Eluting Devices Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Peripheral Intervention Drug-Eluting Devices Average Price (USD/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Peripheral Intervention Drug-Eluting Devices Manufacturing Sites and Area Served
Table 11. Manufacturers Peripheral Intervention Drug-Eluting Devices Product Type
Table 12. Global Peripheral Intervention Drug-Eluting Devices Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Peripheral Intervention Drug-Eluting Devices by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Peripheral Intervention Drug-Eluting Devices as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Peripheral Intervention Drug-Eluting Devices Sales by Region (2016-2021) & (K Units)
Table 16. Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Region (2016-2021)
Table 17. Global Peripheral Intervention Drug-Eluting Devices Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Peripheral Intervention Drug-Eluting Devices Sales by Country (2016-2021) & (K Units)
Table 19. North America Peripheral Intervention Drug-Eluting Devices Sales Market Share by Country (2016-2021)
Table 20. North America Peripheral Intervention Drug-Eluting Devices Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Country (2016-2021)
Table 22. Europe Peripheral Intervention Drug-Eluting Devices Sales by Country (2016-2021) & (K Units)
Table 23. Europe Peripheral Intervention Drug-Eluting Devices Sales Market Share by Country (2016-2021)
Table 24. Europe Peripheral Intervention Drug-Eluting Devices Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Peripheral Intervention Drug-Eluting Devices Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Peripheral Intervention Drug-Eluting Devices Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Peripheral Intervention Drug-Eluting Devices Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Region (2016-2021)
Table 30. Latin America Peripheral Intervention Drug-Eluting Devices Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Peripheral Intervention Drug-Eluting Devices Sales Market Share by Country (2016-2021)
Table 32. Latin America Peripheral Intervention Drug-Eluting Devices Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Peripheral Intervention Drug-Eluting Devices Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Peripheral Intervention Drug-Eluting Devices Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Peripheral Intervention Drug-Eluting Devices Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Country (2016-2021)
Table 38. Global Peripheral Intervention Drug-Eluting Devices Sales (K Units) by Type (2016-2021)
Table 39. Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Type (2016-2021)
Table 40. Global Peripheral Intervention Drug-Eluting Devices Revenue (Million US$) by Type (2016-2021)
Table 41. Global Peripheral Intervention Drug-Eluting Devices Revenue Share by Type (2016-2021)
Table 42. Global Peripheral Intervention Drug-Eluting Devices Price (USD/Unit) by Type (2016-2021)
Table 43. Global Peripheral Intervention Drug-Eluting Devices Sales (K Units) by Application (2016-2021)
Table 44. Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Application (2016-2021)
Table 45. Global Peripheral Intervention Drug-Eluting Devices Revenue (Million US$) by Application (2016-2021)
Table 46. Global Peripheral Intervention Drug-Eluting Devices Revenue Share by Application (2016-2021)
Table 47. Global Peripheral Intervention Drug-Eluting Devices Price (USD/Unit) by Application (2016-2021)
Table 48. Medtronic plc Corporation Information
Table 49. Medtronic plc Description and Business Overview
Table 50. Medtronic plc Peripheral Intervention Drug-Eluting Devices Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 51. Medtronic plc Peripheral Intervention Drug-Eluting Devices Product
Table 52. Medtronic plc Recent Developments/Updates
Table 53. Boston Scientific Corporation Corporation Information
Table 54. Boston Scientific Corporation Description and Business Overview
Table 55. Boston Scientific Corporation Peripheral Intervention Drug-Eluting Devices Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 56. Boston Scientific Corporation Peripheral Intervention Drug-Eluting Devices Product
Table 57. Boston Scientific Corporation Recent Developments/Updates
Table 58. Abbott Laboratories Corporation Information
Table 59. Abbott Laboratories Description and Business Overview
Table 60. Abbott Laboratories Peripheral Intervention Drug-Eluting Devices Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 61. Abbott Laboratories Peripheral Intervention Drug-Eluting Devices Product
Table 62. Abbott Laboratories Recent Developments/Updates
Table 63. Cardinal Health Corporation Information
Table 64. Cardinal Health Description and Business Overview
Table 65. Cardinal Health Peripheral Intervention Drug-Eluting Devices Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 66. Cardinal Health Peripheral Intervention Drug-Eluting Devices Product
Table 67. Cardinal Health Recent Developments/Updates
Table 68. B. Braun Melsungen AG Corporation Information
Table 69. B. Braun Melsungen AG Description and Business Overview
Table 70. B. Braun Melsungen AG Peripheral Intervention Drug-Eluting Devices Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 71. B. Braun Melsungen AG Peripheral Intervention Drug-Eluting Devices Product
Table 72. B. Braun Melsungen AG Recent Developments/Updates
Table 73. Biosensors International Group Ltd. Corporation Information
Table 74. Biosensors International Group Ltd. Description and Business Overview
Table 75. Biosensors International Group Ltd. Peripheral Intervention Drug-Eluting Devices Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 76. Biosensors International Group Ltd. Peripheral Intervention Drug-Eluting Devices Product
Table 77. Biosensors International Group Ltd. Recent Developments/Updates
Table 78. C.R. Bard, Inc. Corporation Information
Table 79. C.R. Bard, Inc. Description and Business Overview
Table 80. C.R. Bard, Inc. Peripheral Intervention Drug-Eluting Devices Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 81. C.R. Bard, Inc. Peripheral Intervention Drug-Eluting Devices Product
Table 82. C.R. Bard, Inc. Recent Developments/Updates
Table 83. Abbott Corporation Information
Table 84. Abbott Description and Business Overview
Table 85. Abbott Peripheral Intervention Drug-Eluting Devices Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 86. Abbott Peripheral Intervention Drug-Eluting Devices Product
Table 87. Abbott Recent Developments/Updates
Table 88. The Lubrizol Corporation Corporation Information
Table 89. The Lubrizol Corporation Description and Business Overview
Table 90. The Lubrizol Corporation Peripheral Intervention Drug-Eluting Devices Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 91. The Lubrizol Corporation Peripheral Intervention Drug-Eluting Devices Product
Table 92. The Lubrizol Corporation Recent Developments/Updates
Table 93. Terumo Corporation Corporation Information
Table 94. Terumo Corporation Description and Business Overview
Table 95. Terumo Corporation Peripheral Intervention Drug-Eluting Devices Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 96. Terumo Corporation Peripheral Intervention Drug-Eluting Devices Product
Table 97. Terumo Corporation Recent Developments/Updates
Table 98. Production Base and Market Concentration Rate of Raw Material
Table 99. Key Suppliers of Raw Materials
Table 100. Peripheral Intervention Drug-Eluting Devices Distributors List
Table 101. Peripheral Intervention Drug-Eluting Devices Customers List
Table 102. Peripheral Intervention Drug-Eluting Devices Market Trends
Table 103. Peripheral Intervention Drug-Eluting Devices Growth Drivers
Table 104. Peripheral Intervention Drug-Eluting Devices Market Restraints
Table 105. Global Peripheral Intervention Drug-Eluting Devices Sales Forecast by Type (2022-2027) & (K Units)
Table 106. Global Peripheral Intervention Drug-Eluting Devices Sales Market Share Forecast by Type (2022-2027)
Table 107. Global Peripheral Intervention Drug-Eluting Devices Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 108. Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share Forecast by Type (2022-2027)
Table 109. Global Peripheral Intervention Drug-Eluting Devices Sales Forecast by Application (2022-2027) & (K Units)
Table 110. Global Peripheral Intervention Drug-Eluting Devices Sales Market Share Forecast by Application (2022-2027)
Table 111. Global Peripheral Intervention Drug-Eluting Devices Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 112. Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share Forecast by Application (2022-2027)
Table 113. Global Peripheral Intervention Drug-Eluting Devices Sales Forecast by Region (2022-2027) & (K Units)
Table 114. Global Peripheral Intervention Drug-Eluting Devices Sales Market Share Forecast by Region (2022-2027)
Table 115. Global Peripheral Intervention Drug-Eluting Devices Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 116. Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share Forecast by Region (2022-2027)
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Peripheral Intervention Drug-Eluting Devices
Figure 2. Global Peripheral Intervention Drug-Eluting Devices Market Share by Type in 2020 & 2027
Figure 3. Plain Old Balloon Angioplasty (POBA) Product Picture
Figure 4. Percutaneous Transluminal Angioplasty (PTA) Product Picture
Figure 5. Global Peripheral Intervention Drug-Eluting Devices Market Share by Application in 2020 & 2027
Figure 6. Drug-Eluting Balloons
Figure 7. Drug-Eluting Stents
Figure 8. Global Peripheral Intervention Drug-Eluting Devices Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 9. Global Peripheral Intervention Drug-Eluting Devices Market Size 2016-2027 (US$ Million)
Figure 10. Global Peripheral Intervention Drug-Eluting Devices Sales 2016-2027 (K Units)
Figure 11. Global Peripheral Intervention Drug-Eluting Devices Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 12. Peripheral Intervention Drug-Eluting Devices Sales Share by Manufacturers in 2020
Figure 13. Global Peripheral Intervention Drug-Eluting Devices Revenue Share by Manufacturers in 2020
Figure 14. The Global 5 and 10 Largest Peripheral Intervention Drug-Eluting Devices Players: Market Share by Revenue in 2020
Figure 15. Peripheral Intervention Drug-Eluting Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 16. Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Region (2016-2021)
Figure 17. Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Region in 2020
Figure 18. Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Region (2016-2021)
Figure 19. Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Region in 2020
Figure 20. U.S. Peripheral Intervention Drug-Eluting Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 21. Canada Peripheral Intervention Drug-Eluting Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Germany Peripheral Intervention Drug-Eluting Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. France Peripheral Intervention Drug-Eluting Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. U.K. Peripheral Intervention Drug-Eluting Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Italy Peripheral Intervention Drug-Eluting Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Russia Peripheral Intervention Drug-Eluting Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. China Peripheral Intervention Drug-Eluting Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Japan Peripheral Intervention Drug-Eluting Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. South Korea Peripheral Intervention Drug-Eluting Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. India Peripheral Intervention Drug-Eluting Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Australia Peripheral Intervention Drug-Eluting Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Taiwan Peripheral Intervention Drug-Eluting Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Indonesia Peripheral Intervention Drug-Eluting Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Thailand Peripheral Intervention Drug-Eluting Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Malaysia Peripheral Intervention Drug-Eluting Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Philippines Peripheral Intervention Drug-Eluting Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Vietnam Peripheral Intervention Drug-Eluting Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Mexico Peripheral Intervention Drug-Eluting Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Brazil Peripheral Intervention Drug-Eluting Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Argentina Peripheral Intervention Drug-Eluting Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Turkey Peripheral Intervention Drug-Eluting Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Saudi Arabia Peripheral Intervention Drug-Eluting Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. U.A.E Peripheral Intervention Drug-Eluting Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Sales Market Share of Peripheral Intervention Drug-Eluting Devices by Type (2016-2021)
Figure 45. Sales Market Share of Peripheral Intervention Drug-Eluting Devices by Application (2016-2021)
Figure 46. Sales Market Share of Peripheral Intervention Drug-Eluting Devices by Application in 2020
Figure 47. Revenue Share of Peripheral Intervention Drug-Eluting Devices by Application (2016-2021)
Figure 48. Revenue Share of Peripheral Intervention Drug-Eluting Devices by Application in 2020
Figure 49. Manufacturing Cost Structure of Peripheral Intervention Drug-Eluting Devices
Figure 50. Manufacturing Process Analysis of Peripheral Intervention Drug-Eluting Devices
Figure 51. Peripheral Intervention Drug-Eluting Devices Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed
Keyplayers in Global Peripheral Intervention Drug-Eluting Devices Market Research Report 2021
Medtronic plcBoston Scientific Corporation
Abbott Laboratories
Cardinal Health
B. Braun Melsungen AG
Biosensors International Group Ltd.
C.R. Bard, Inc.
Abbott
The Lubrizol Corporation
Terumo Corporation
